Anemia and blood transfusion in the critically ill patient: Role of erythropoietin

Critical Care

Volumn 8, Issue SUPPL. 2, 2004, Pages

  Corwin, Howard L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Anemia; Blood transfusion; Critical illness; Erythropoietin

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; CRITICAL ILLNESS; DOSE RESPONSE; DRUG EFFICACY; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMATOCRIT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MULTIPLE ORGAN FAILURE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; STATISTICAL SIGNIFICANCE;

ANEMIA; CRITICAL CARE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN, RECOMBINANT; EUROPE; HUMANS; INTENSIVE CARE UNITS; MULTIPLE ORGAN FAILURE; PHLEBOTOMY; TREATMENT OUTCOME; UNITED STATES;

EID: 4344622057     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2411     Document Type: Review

References (26)

1. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ: Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 1999, 27:2346-2350.
2. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG: Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001, 16:36-41.
3. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy AM, Abraham E, MacIntyre NR, Shabot M, Dun MS, Shapiro MJ: The CRIT study: Anemia and blood transfusion in the critically ill: current clinical practice in the United States. Crit Care Med 2004, 32:39-52.
4. Littenberg B, Corwin H, Leichter J, AuBuchon J: A practice guideline and decision aid for blood transfusion. Immunohematology 1995,11:88-94.
5. Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion in the ICU. Is there a reason? Chest 1995, 108:767-771.
6. Vincent JL, Baron J-F, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D: Anemia and blood transfusion in critically ill patients. JAMA 2002, 288:1499-1507.
7. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
8. Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, Tweeddale M, Pagliarello G, Schweitzer I: Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001, 29:227-234.
9. Dietrich KA, Conrad SA, Hebert CA, Levy GL, Romero MID: Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients. Crit Care Med 1990,18:940-944.
10. Consensus Development Conference on Perioperative Red Cell Transfusion: Consensus conference. Perioperative red blood cell transfusion. JAMA 1988, 260:2700-2703.
11. American College of Physicians: Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992, 116:403-406.
12. Smoller BR, Kruskall MS: Phlebotomy for diagnostic laboratory tests in adults: pattern of use and effect on transfusion requirements. N Engl J Med 1986, 314:1233-1235.
13. Eyster E, Bernene J: Nosocomial anemia. JAMA 1973, 223:73-74.
14. Tarpey J, Lawler PG: Iatrogenic anaemia? A survey of venesection in patients in the intensive therapy unit. Anaesthesia 1990, 45:396-398.
15. Burnum JF: Medical vampires. N Engl J Med 1986, 314:1250-1251.
16. van Iperen CE, Gaillard CAM, Kraaijenhagen RJ, Braam BG, Marx JJM, van de Wiel A: Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28:2773-2778.
17. Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG: High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 1998, 44:361-367.
18. Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Melot C, Vincent J-L: Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997, 23:159-162.
19. Krafte-Jacobs B, Levetown ML, Bray GL, Ruttimann UE, Pollack MM: Erythropoietin response to critical illness. Crit Care Med 1994, 22:821-826.
20. Frede S, Fandrey J, Pagel H, Hellwig T, Jelkmann W: Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Am J Physiol 1997, 273: R1067-R1071.
21. Jelkmann W: Proinflarnmatory cytolkines lowering erythropoietin production. J Interferon Cytokine Res 1998, 18:555-559.
22. Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992, 80: 1639-1647.
23. Krantz SB: Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci 1994, 307:353-359.
24. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T: Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002, 288:2827-2835.
25. Silver M, Bazan A, Corwin H, Gettinger A, Enny C, Corwin MJ: Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin in long-term acute care patients [abstract]. Crit Care Med 2003, 31:A153.
26. Corwin HL, Krantz SB: Anemia of the critically ill: 'acute' anemia of chronic disease [editorial]. Crit Care Med 2000, 28: 3098-3099.